The three Wegovy products: FDA label revised June 2026; NovoCare self-pay read November 8, 2026 (pen month = 4 pens; pill month = 30 tablets)
Wegovy penWegovy HDWegovy pill
How takenInjection once weeklyInjection once weeklyTablet once daily
Strengths0.25, 0.5, 1, 1.7, 2.4 mg7.2 mg1.5, 4, 9, 25 mg
Weight managementAdults; children 12 and older with obesityAdults, after at least 4 weeks on 2.4 mgAdults
Cardiovascular risk reductionYesNot listed (CV maintenance dose is 2.4 or 1.7 mg)Yes
MASH with F2 to F3 fibrosisYes (accelerated approval)NoNo
Self-pay$349 a month; new patients $199 for two fills of 0.25 or 0.5 mg through Dec 31, 2026$399 a month$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)

What is Wegovy approved for?

Wegovy has three approved uses, each paired with a reduced-calorie diet and more activity. The injection is approved to reduce excess weight and keep it off in adults and in children 12 and older with obesity, and in adults with overweight plus a weight-related condition.

Both the injection and the tablets are approved to lower the risk of cardiovascular death, heart attack or stroke in adults with established cardiovascular disease and obesity or overweight. FDA announced that use on March 8, 2024, citing a trial of more than 17,600 people in which these events occurred in 6.5% on Wegovy and 8% on placebo. FDA's release does not name the trial; the published paper calls it SELECT and reports a hazard ratio of 0.80. Details are in our SELECT summary.

The injection alone is approved for noncirrhotic MASH (formerly NASH) with moderate to advanced liver fibrosis in adults. That is an accelerated approval, so continued approval may depend on a confirmatory trial. See GLP-1 drugs and fatty liver.

How is the Wegovy pen dosed?

The pen climbs every 4 weeks from 0.25 mg to a maintenance dose reached at week 17. The label's escalation runs as follows.

  1. Weeks 1 to 4: 0.25 mg once weekly.
  2. Weeks 5 to 8: 0.5 mg.
  3. Weeks 9 to 12: 1 mg.
  4. Weeks 13 to 16: 1.7 mg.
  5. Week 17 on: 2.4 mg (recommended) or 1.7 mg for adult weight management; 2.4 mg recommended for MASH.

If a step is hard to tolerate, the label suggests delaying the next increase by 4 weeks. Missing two or more doses in a row means restarting at a lower dose. Besides the single-dose pens, the label lists a 4-dose FlexTouch pen at 2.4 mg and single-dose syringes.

Who is Wegovy HD 7.2 mg for?

Wegovy HD is a higher maintenance dose for adult weight management. The label allows moving to 7.2 mg weekly only after at least 4 weeks on 2.4 mg, and only when more weight reduction is clinically indicated.

In the label's Study 8, adults with obesity on 7.2 mg lost a mean 18.8% of body weight at 72 weeks, versus 15.5% on 2.4 mg and 3.9% on placebo. Nausea was more common at the higher dose: 39% on 7.2 mg, 35% on 2.4 mg and 13% on placebo in that analysis.

How is the Wegovy pill taken?

The tablet starts at 1.5 mg once daily and steps up every 30 days to a 25 mg maintenance dose from day 91: 1.5 mg on days 1 to 30, 4 mg on days 31 to 60, 9 mg on days 61 to 90, then 25 mg.

In the label's 64-week Study 7, adults on 25 mg tablets lost a mean 13.6% of body weight versus 2.4% on placebo. The label also explains switching: one week after stopping the 2.4 mg injection you can start 25 mg tablets, and the day after stopping 25 mg tablets you can start the 2.4 mg injection. Wegovy should not be combined with other semaglutide products or other GLP-1 drugs.

How much does Wegovy cost without insurance?

Through NovoCare, the pen costs $349 a month at every dose from 0.25 mg to 2.4 mg, and Wegovy HD costs $399. New self-pay patients get the first two fills of 0.25 mg or 0.5 mg at $199 each, through December 31, 2026. NovoCare says pricing will be updated after that date.

As arithmetic only: a new patient who uses the two $199 starter fills and then 10 fills at $349 would pay $3,888 for 12 pen fills. Because each fill is 4 weekly doses, 12 fills cover 48 weeks, not a full year. The pill at 25 mg would be $299 × 12 = $3,588 for 12 bottles of 30 tablets.

Does Medicare cover Wegovy?

Yes, for eligible people through the Medicare GLP-1 Bridge. Medicare.gov lists Wegovy as an injection or tablet, with a $50 monthly copay from July 1, 2026 through December 31, 2027. Eligibility starts at a BMI of 35, or lower BMIs with listed conditions.

One gap stands out: people with fatty liver disease are not eligible for the Bridge, even though the Wegovy injection carries a MASH indication. People with type 2 diabetes or moderate-to-severe sleep apnea are also excluded; Medicare.gov says their Part D plan "might cover" a GLP-1. Our Medicare Part D page walks through the rules.

What are Wegovy's main safety warnings?

Wegovy carries a boxed warning for thyroid C-cell tumors seen in rodents and is not for people with a personal or family history of medullary thyroid carcinoma or with MEN 2. In the label's weight trials of the 2.4 mg injection, nausea affected 44% versus 16% on placebo, diarrhea 30% versus 16%, and vomiting and constipation 24% each versus 6% and 11%.

Other warnings cover pancreatitis, gallbladder disease, low blood sugar with diabetes drugs, kidney injury from dehydration, allergic reactions, diabetic eye complications, heart rate increase and aspiration under anesthesia. For how Wegovy relates to Ozempic, read Ozempic vs Wegovy.

Frequently asked questions

Is the Wegovy pill as effective as the injection?

The label does not compare them head to head. In the label's 64-week Study 7, adults on 25 mg tablets lost a mean 13.6% of body weight versus 2.4% on placebo. In STEP 1, the 2.4 mg injection produced a mean 14.9% loss versus 2.4% at 68 weeks. Different trials, populations and lengths mean these numbers cannot be compared directly.

When can someone move up to Wegovy HD 7.2 mg?

The label allows 7.2 mg weekly only for adults using Wegovy for weight reduction who have tolerated 2.4 mg for at least 4 weeks and need more weight reduction. It is not listed as a maintenance dose for children or for MASH. Your prescriber decides whether the higher dose is appropriate for you.

How long does a month of Wegovy last?

NovoCare defines a month as one box of 4 pens for the injection, which is 4 weekly doses or 28 days, and one bottle of 30 tablets for the pill. So 12 pen fills cover 48 weeks. That matters when you compare annual costs with programs that bill by calendar month.

Can I get Wegovy for fatty liver through Medicare?

Not through the Medicare GLP-1 Bridge. Medicare.gov says people with fatty liver disease, type 2 diabetes or moderate-to-severe sleep apnea are not eligible for the Bridge, although their Part D plan might cover a GLP-1. The Bridge itself covers Wegovy injection or tablets, Foundayo and the Zepbound KwikPen at a $50 monthly copay through December 31, 2027.

Is compounded semaglutide the same as Wegovy?

No. Compounded semaglutide is made with the drug in Wegovy, but it is not the same product and is not FDA-approved. FDA says it does not review compounded drugs for safety, effectiveness or quality, and it has warned that some compounders use semaglutide salt forms, which it calls different active ingredients with no known lawful basis for compounding.

Sources

  1. FDA label (DailyMed): Wegovy injection and tablets prescribing information — label revised 06/2026 (SPL effective June 18, 2026); sections 1, 2, 3, 6.1, 14 read 2026-11-08
  2. FDA: FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight — press release March 8, 2024; read 2026-11-08 (trial not named in release)
  3. Drugs@FDA: Wegovy injection (NDA 215256) and Wegovy tablets (NDA 218316) — injection approved June 4, 2021; tablets approved December 22, 2025; queried 2026-11-08
  4. NovoCare: Wegovy savings offer and self-pay pricing — read 2026-11-08; matches facts file
  5. Medicare.gov: Weight loss drugs (Medicare GLP-1 Bridge) — read 2026-11-08
  6. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med 2023;389:2221-2232 — published December 14, 2023; abstract read 2026-11-08

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.